GlassScriptPhysician profile
Maxwell Q Nyce
NPI 1700375854
$1,188.55
in general payments reported to CMS, 2019-2025
22 companies · $662 in 2025
The $662 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $123 · 2023: $56.23 · 2024: $347 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,065.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $302.57 | 2024-2025 | |
| Medtronic, INC. | $122.89 | 2022 | |
| Acadia Pharmaceuticals INC | $72.96 | 2025 | Nuplazid |
| Genentech USA, INC. | $68.97 | 2025 | Ocrevus Zunovo |
| Lilly USA, LLC | $63.39 | 2024-2025 | Kisunla, Emgality |
| Insightec,INC | $56.23 | 2023 | Exablate |
| Lundbeck LLC | $51.94 | 2024-2025 | Vyepti |
| Emd Serono, INC. | $48.02 | 2025 | |
| Biogen, INC. | $45.51 | 2025 | Vumerity, Tysabri |
| Harmony Biosciences LLC | $39.62 | 2025 | |
| Pfizer INC. | $37.28 | 2025 | |
| Abbott Laboratories | $35.27 | 2024-2025 | Infinity |
| Novartis Pharmaceuticals Corporation | $34.23 | 2025 | |
| Celgene Corporation | $29.23 | 2024-2025 | Zeposia |
| Mirum Pharmaceuticals, INC. | $27.62 | 2024 | Cholbam |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $26.79 | 2025 | |
| Sk Life Science, INC. | $25.74 | 2024 | |
| Neurocrine Biosciences, INC. | $24.49 | 2024 | Ingrezza |
| Astrazeneca Pharmaceuticals LP | $22.49 | 2025 | |
| Livanova USA, INC. | $19.71 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Ceribell, INC. | $18.75 | 2025 | Pocket Eeg Device |
| Teva Pharmaceuticals USA, INC. | $14.85 | 2024 | Ajovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxwell Nyce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.